Rabeprazole sodium for gastroesophageal reflux

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Aug 2008: Trial started, NCT00838526
  2. 6 Feb 2009: Trial registered, NCT00838526

The trials

NCT00838526: Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

State
Completed
Phase
Phase 3
People
240 taking part
Started
31 Aug 2008
Primary completion
31 Jul 2009
Arms
1
Results
Posted on the registry
  1. 31 Aug 2008: Trial started
  2. 6 Feb 2009: Trial registered
  3. 31 Dec 2009: Trial completed
  4. 23 Jun 2015: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Aciphex, Idiazole, Pariet, Rabeprazole ER.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.